All journal publications (1963-2013)

Found 19 results. Export: Tagged | XML
Sort by:[Year][Author]
Filters: author is Driessen  [Clear All Filters]
2012
2011
Kraus, M., Bader, J., Hess, D., Haile, S., Overkleeft, H., Driessen, C., Sakk, , The HIV protease inhibitor Nelfinavir has proteasome-inhibiting activity in vivo distinct from Bortezomib, Onkologie, vol. 34, pp. 159-159.
2009
Clerc, J., Florea, B. I, Kraus, M., Groll, M., Huber, R., Bachmann, A.S., Dudler, R., Driessen, C., Overkleeft, H.S., Kaiser, M. , Syringolin A Selectively Labels the 20 S Proteasome in Murine EL4 and Wild-Type and Bortezomib-Adapted Leukaemic Cell Lines, Chembiochem, vol. 10, no. 16, pp. 2638-2643. DOI
Ruckrich, T., Kraus, M., Gogel, J., Beck, A., Ovaa, H., Verdoes, M., Overkleeft, H.S., Kalbacher, H., Driessen, C. , Characterization of the ubiquitin-proteasome system in bortezomib-adapted cells, Leukemia, vol. 23, no. 6, pp. 1098-1105. DOI
Hillaert, U., Verdoes, M., Florea, B. I, Saragliadis, A., Habets, K.L., Kuiper, J., Van Calenbergh, S., Ossendorp, F., van der Marel, G.A., Driessen, C., Overkleeft, H.S. , Receptor-Mediated Targeting of Cathepsins in Professional Antigen Presenting Cells, Angew Chem Int Ed Engl. DOI
2008
Fissolo, N., Kraus, M., Reich, M., Ayturan, M., Overkleeft, H., Driessen, C., Weissert, R. , Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation, European Journal of Immunology, vol. 38, no. 9, pp. 2401-2411. DOI
Kessler, T., Reich, M., Jahn, G., Tolosa, E., Beck, A., Kalbacher, H., Overkleeft, H., Schempp, S., Driessen, C. , Human cytomegalovirus infection interferes with major histocompatibility complex type II maturation and endocytic proteases in dendritic cells at multiple levels, Journal of General Virology, vol. 89, pp. 2427-2436. DOI
Kraus, M., Malenke, E., Gogel, J., Muller, H., Ruckrich, T., Overkleeft, H., Ovaa, H., Koscielniak, E., Hartmann, J.T., Driessen, C. , Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis, Molecular Cancer Therapeutics, vol. 7, no. 7, pp. 1940-1948. DOI
2007
Burster, T., Beck, A., Poeschel, S., Oren, A., Baechle, D., Reich, M., Roetzschke, O., Falk, K., Boehm, B.O., Youssef, S., Kalbacher, H., Overkleeft, H., Tolosa, E., Driessen, C. , Interferon-gamma regulates cathepsin G activity in microglia-derived lysosomes and controls the proteolytic processing of myelin basic protein in vitro, Immunology, vol. 121, no. 1, pp. 82-93. DOI
Kraus, M., Ruckrich, T., Reich, M., Gogel, J., Beck, A., Kammer, W., Berkers, C.R., Burg, D., Overkleeft, H., Ovaa, H., Driessen, C. , Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells, Leukemia, vol. 21, no. 1, pp. 84-92.
Reich, M., van Swieten, P.F., Sommandas, V., Kraus, M., Fischer, R., Weber, E., Kalbacher, H., Overkleeft, H.S., Driessen, C. , Endocytosis targets exogenous material selectively to cathepsin S in live human dendritic cells, while cellpenetrating peptides mediate nonselective transport to cysteine cathepsins, Journal of Leukocyte Biology, vol. 81, no. 4, pp. 990-1001. DOI
2005
Burster, T., Beck, A., Tolosa, E., Schnorrer, P., Weissert, R., Reich, M., Kraus, M., Kalbacher, H., Haring, H.U., Weber, E., Overkleeft, H., Driessen, C. , Differential processing of autoantigens in lysosomes from human monocyte-derived and peripheral blood dendritic cells, Journal of Immunology, vol. 175, no. 9, pp. 5940-5949.
van Zutphen, S., Kraus, M., Driessen, C., van der Marel, G.A., Overkleeft, H.S., Reedijk, J. , Probing the potential of platinum(II) complexes for the inhibition of thiol-dependent enzymatic activity, Journal of Inorganic Biochemistry, vol. 99, no. 6, pp. 1384-1389.
2004
Lautwein, A., Kraus, M., Reich, M., Burster, T., Brandenburg, J., Overkleeft, H.S., Schwarz, G., Kammer, W., Weber, E., Kalbacher, H., Nordheim, A., Driessen, C. , Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner, Journal of Leukocyte Biology, vol. 75, no. 5, pp. 844-855.
van Swieten, P.F., Maehr, R., van den Nieuwendijk, A.M.C.H., Kessler, B.M., Reich, M., Wong, C.S., Kalbacher, H., Leeuwenburgh, M.A., Driessen, C., van der Marel, G.A., Ploegh, H.L., Overkleeft, H.S. , Development of an isotope-coded activity-based probe for the quantitative profiling of cysteine proteases, Bioorganic & Medicinal Chemistry Letters, vol. 14, no. 12, pp. 3131-3134.
2003
Wiendl, H., Lautwein, A., Mitsdorffer, M., Krause, S., Erfurth, S., Wienhold, W., Morgalla, M., Weber, E., Overkleeft, H.S., Lochmuller, H., Melms, A., Tolosa, E., Driessen, C. , Antigen processing and presentation in human muscle: cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies, Journal of Neuroimmunology, vol. 138, no. 1-2, pp. 132-143.
Greiner, A., Lautwein, A., Overkleeft, H.S., Weber, E., Driessen, C. , Activity and subcellular distribution of cathepsins in primary human monocytes, Journal of Leukocyte Biology, vol. 73, no. 2, pp. 235-242.
2002
Lautwein, A., Burster, T., Lennon-Dumenil, A.M., Overkleeft, H.S., Weber, E., Kalbacher, H., Driessen, C. , Inflammatory stimuli recruit cathepsin activity to late endosomal compartments in human dendritic cells, European Journal of Immunology, vol. 32, no. 12, pp. 3348-3357.
2001
Lennon-Dumenil, A.M., Roberts, R.A., Valentijn, K., Driessen, C., Overkleeft, H.S., Erickson, A., Peters, P.J., Bikoff, E., Ploegh, H.L., Bryant, P.W. , The p41 isoform of invariant chain is a chaperone for cathepsin L, Embo Journal, vol. 20, no. 15, pp. 4055-4064.